Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Antimicrobial Efficacy Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Antimicrobial Efficacy Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 198 Pages
Report ld: 5346366
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Antimicrobial Efficacy Testing Market Size(US$)
CAGR 2025-2031
3.9%
Market Size,2031
USD 425
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 338 million
Market Forecast in 2031(Value)
US$ 425 million
CAGR
3.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Antimicrobial Efficacy Testing market is projected to grow from US$ 326 million in 2024 to US$ 425 million by 2031, at a CAGR of 3.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Efficacy Testing is a set of procedures in product research and development that are conducted to test the product’s intended purpose in order to substantiate those all-important claims that appear on your packaging or in your advertisements.
The Antimicrobial Efficacy Testing market was experiencing growth due to increasing concerns about antimicrobial resistance, infection control, and the need to ensure the effectiveness of antimicrobial products and treatments. Antimicrobial efficacy testing involves assessing the ability of antimicrobial agents to inhibit or kill microorganisms such as bacteria, viruses, and fungi.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Antimicrobial Efficacy Testing market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Charles River Laboratories
- WuXi AppTec
- Eurofins Scientific
- SGS
- Intertek Group
- Nelson Laboratories
- Microbac Laboratories
- Almac Group
- North American Science Associates
- Toxikon
- Pacific Biolabs
- MSL Solution Providers
- Accugen Laboratories
- Consumer Product Testing Company
- Lucideon
- BioScience Laboratories
- ALS Limited
- Microchem Laboratory
- Oxford Biosciences Ltd.
- Abbott Analytical
- Helvic Laboratories
- Honeyman Group Limited
- Danish Technological Institute
- BluTest Laboratories Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Preservative Efficacy Testing
- Disinfectant Efficacy Testing
Segment by Application
- Pharmaceutical Manufacturing
- Cosmetics and Personal Care Product
- Medical Device
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Antimicrobial Efficacy Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Antimicrobial Efficacy Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antimicrobial Efficacy Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Preservative Efficacy Testing
1.2.3 Disinfectant Efficacy Testing
1.3 Market Segmentation by Application
1.3.1 Global Antimicrobial Efficacy Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Manufacturing
1.3.3 Cosmetics and Personal Care Product
1.3.4 Medical Device
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antimicrobial Efficacy Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Antimicrobial Efficacy Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Antimicrobial Efficacy Testing Sales Estimates and Forecasts 2020-2031
2.4 Global Antimicrobial Efficacy Testing Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Antimicrobial Efficacy Testing Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Antimicrobial Efficacy Testing Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Preservative Efficacy Testing Market Size by Manufacturers
3.5.2 Disinfectant Efficacy Testing Market Size by Manufacturers
3.6 Global Antimicrobial Efficacy Testing Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Antimicrobial Efficacy Testing Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Antimicrobial Efficacy Testing Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Antimicrobial Efficacy Testing Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Antimicrobial Efficacy Testing Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Antimicrobial Efficacy Testing Sales and Revenue by Type (2020-2031)
6.4 North America Antimicrobial Efficacy Testing Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Antimicrobial Efficacy Testing Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Antimicrobial Efficacy Testing Sales and Revenue by Type (2020-2031)
7.4 Europe Antimicrobial Efficacy Testing Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Antimicrobial Efficacy Testing Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Antimicrobial Efficacy Testing Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Antimicrobial Efficacy Testing Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Antimicrobial Efficacy Testing Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Antimicrobial Efficacy Testing Sales and Revenue by Type (2020-2031)
9.4 Central and South America Antimicrobial Efficacy Testing Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Antimicrobial Efficacy Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Antimicrobial Efficacy Testing Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Antimicrobial Efficacy Testing Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Antimicrobial Efficacy Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Corporation Information
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.1.4 Charles River Laboratories Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Charles River Laboratories Antimicrobial Efficacy Testing Sales by Product in 2024
11.1.6 Charles River Laboratories Antimicrobial Efficacy Testing Sales by Application in 2024
11.1.7 Charles River Laboratories Antimicrobial Efficacy Testing Sales by Geographic Area in 2024
11.1.8 Charles River Laboratories Antimicrobial Efficacy Testing SWOT Analysis
11.1.9 Charles River Laboratories Recent Developments
11.2 WuXi AppTec
11.2.1 WuXi AppTec Corporation Information
11.2.2 WuXi AppTec Business Overview
11.2.3 WuXi AppTec Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.2.4 WuXi AppTec Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 WuXi AppTec Antimicrobial Efficacy Testing Sales by Product in 2024
11.2.6 WuXi AppTec Antimicrobial Efficacy Testing Sales by Application in 2024
11.2.7 WuXi AppTec Antimicrobial Efficacy Testing Sales by Geographic Area in 2024
11.2.8 WuXi AppTec Antimicrobial Efficacy Testing SWOT Analysis
11.2.9 WuXi AppTec Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Corporation Information
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.3.4 Eurofins Scientific Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Eurofins Scientific Antimicrobial Efficacy Testing Sales by Product in 2024
11.3.6 Eurofins Scientific Antimicrobial Efficacy Testing Sales by Application in 2024
11.3.7 Eurofins Scientific Antimicrobial Efficacy Testing Sales by Geographic Area in 2024
11.3.8 Eurofins Scientific Antimicrobial Efficacy Testing SWOT Analysis
11.3.9 Eurofins Scientific Recent Developments
11.4 SGS
11.4.1 SGS Corporation Information
11.4.2 SGS Business Overview
11.4.3 SGS Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.4.4 SGS Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 SGS Antimicrobial Efficacy Testing Sales by Product in 2024
11.4.6 SGS Antimicrobial Efficacy Testing Sales by Application in 2024
11.4.7 SGS Antimicrobial Efficacy Testing Sales by Geographic Area in 2024
11.4.8 SGS Antimicrobial Efficacy Testing SWOT Analysis
11.4.9 SGS Recent Developments
11.5 Intertek Group
11.5.1 Intertek Group Corporation Information
11.5.2 Intertek Group Business Overview
11.5.3 Intertek Group Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.5.4 Intertek Group Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Intertek Group Antimicrobial Efficacy Testing Sales by Product in 2024
11.5.6 Intertek Group Antimicrobial Efficacy Testing Sales by Application in 2024
11.5.7 Intertek Group Antimicrobial Efficacy Testing Sales by Geographic Area in 2024
11.5.8 Intertek Group Antimicrobial Efficacy Testing SWOT Analysis
11.5.9 Intertek Group Recent Developments
11.6 Nelson Laboratories
11.6.1 Nelson Laboratories Corporation Information
11.6.2 Nelson Laboratories Business Overview
11.6.3 Nelson Laboratories Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.6.4 Nelson Laboratories Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Nelson Laboratories Recent Developments
11.7 Microbac Laboratories
11.7.1 Microbac Laboratories Corporation Information
11.7.2 Microbac Laboratories Business Overview
11.7.3 Microbac Laboratories Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.7.4 Microbac Laboratories Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Microbac Laboratories Recent Developments
11.8 Almac Group
11.8.1 Almac Group Corporation Information
11.8.2 Almac Group Business Overview
11.8.3 Almac Group Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.8.4 Almac Group Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Almac Group Recent Developments
11.9 North American Science Associates
11.9.1 North American Science Associates Corporation Information
11.9.2 North American Science Associates Business Overview
11.9.3 North American Science Associates Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.9.4 North American Science Associates Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 North American Science Associates Recent Developments
11.10 Toxikon
11.10.1 Toxikon Corporation Information
11.10.2 Toxikon Business Overview
11.10.3 Toxikon Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.10.4 Toxikon Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Toxikon Recent Developments
11.11 Pacific Biolabs
11.11.1 Pacific Biolabs Corporation Information
11.11.2 Pacific Biolabs Business Overview
11.11.3 Pacific Biolabs Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.11.4 Pacific Biolabs Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Pacific Biolabs Recent Developments
11.12 MSL Solution Providers
11.12.1 MSL Solution Providers Corporation Information
11.12.2 MSL Solution Providers Business Overview
11.12.3 MSL Solution Providers Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.12.4 MSL Solution Providers Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 MSL Solution Providers Recent Developments
11.13 Accugen Laboratories
11.13.1 Accugen Laboratories Corporation Information
11.13.2 Accugen Laboratories Business Overview
11.13.3 Accugen Laboratories Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.13.4 Accugen Laboratories Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Accugen Laboratories Recent Developments
11.14 Consumer Product Testing Company
11.14.1 Consumer Product Testing Company Corporation Information
11.14.2 Consumer Product Testing Company Business Overview
11.14.3 Consumer Product Testing Company Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.14.4 Consumer Product Testing Company Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Consumer Product Testing Company Recent Developments
11.15 Lucideon
11.15.1 Lucideon Corporation Information
11.15.2 Lucideon Business Overview
11.15.3 Lucideon Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.15.4 Lucideon Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Lucideon Recent Developments
11.16 BioScience Laboratories
11.16.1 BioScience Laboratories Corporation Information
11.16.2 BioScience Laboratories Business Overview
11.16.3 BioScience Laboratories Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.16.4 BioScience Laboratories Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 BioScience Laboratories Recent Developments
11.17 ALS Limited
11.17.1 ALS Limited Corporation Information
11.17.2 ALS Limited Business Overview
11.17.3 ALS Limited Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.17.4 ALS Limited Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 ALS Limited Recent Developments
11.18 Microchem Laboratory
11.18.1 Microchem Laboratory Corporation Information
11.18.2 Microchem Laboratory Business Overview
11.18.3 Microchem Laboratory Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.18.4 Microchem Laboratory Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Microchem Laboratory Recent Developments
11.19 Oxford Biosciences Ltd.
11.19.1 Oxford Biosciences Ltd. Corporation Information
11.19.2 Oxford Biosciences Ltd. Business Overview
11.19.3 Oxford Biosciences Ltd. Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.19.4 Oxford Biosciences Ltd. Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Oxford Biosciences Ltd. Recent Developments
11.20 Abbott Analytical
11.20.1 Abbott Analytical Corporation Information
11.20.2 Abbott Analytical Business Overview
11.20.3 Abbott Analytical Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.20.4 Abbott Analytical Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Abbott Analytical Recent Developments
11.21 Helvic Laboratories
11.21.1 Helvic Laboratories Corporation Information
11.21.2 Helvic Laboratories Business Overview
11.21.3 Helvic Laboratories Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.21.4 Helvic Laboratories Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Helvic Laboratories Recent Developments
11.22 Honeyman Group Limited
11.22.1 Honeyman Group Limited Corporation Information
11.22.2 Honeyman Group Limited Business Overview
11.22.3 Honeyman Group Limited Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.22.4 Honeyman Group Limited Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Honeyman Group Limited Recent Developments
11.23 Danish Technological Institute
11.23.1 Danish Technological Institute Corporation Information
11.23.2 Danish Technological Institute Business Overview
11.23.3 Danish Technological Institute Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.23.4 Danish Technological Institute Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Danish Technological Institute Recent Developments
11.24 BluTest Laboratories Limited
11.24.1 BluTest Laboratories Limited Corporation Information
11.24.2 BluTest Laboratories Limited Business Overview
11.24.3 BluTest Laboratories Limited Antimicrobial Efficacy Testing Product Models, Descriptions and Specifications
11.24.4 BluTest Laboratories Limited Antimicrobial Efficacy Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 BluTest Laboratories Limited Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Antimicrobial Efficacy Testing Industry Chain
12.2 Antimicrobial Efficacy Testing Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Antimicrobial Efficacy Testing Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Antimicrobial Efficacy Testing Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Antimicrobial Efficacy Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Antimicrobial Efficacy Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Antimicrobial Efficacy Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Antimicrobial Efficacy Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Antimicrobial Efficacy Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Antimicrobial Efficacy Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Antimicrobial Efficacy Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Antimicrobial Efficacy Testing Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Antimicrobial Efficacy Testing Sales by Region (2020-2025) & (K Units)
Table 8. Global Antimicrobial Efficacy Testing Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Antimicrobial Efficacy Testing Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Antimicrobial Efficacy Testing Sales Share by Manufacturers (2020-2025)
Table 12. Global Antimicrobial Efficacy Testing Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Antimicrobial Efficacy Testing Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Antimicrobial Efficacy Testing by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Efficacy Testing as of 2024)
Table 16. Global Antimicrobial Efficacy Testing Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Antimicrobial Efficacy Testing Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Antimicrobial Efficacy Testing Manufacturing Base and Headquarters
Table 19. Global Antimicrobial Efficacy Testing Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Antimicrobial Efficacy Testing Sales by Type (2020-2025) & (K Units)
Table 23. Global Antimicrobial Efficacy Testing Sales by Type (2026-2031) & (K Units)
Table 24. Global Antimicrobial Efficacy Testing Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Antimicrobial Efficacy Testing Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Antimicrobial Efficacy Testing ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Antimicrobial Efficacy Testing Sales by Application (2020-2025) & (K Units)
Table 29. Global Antimicrobial Efficacy Testing Sales by Application (2026-2031) & (K Units)
Table 30. Antimicrobial Efficacy Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Antimicrobial Efficacy Testing Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Antimicrobial Efficacy Testing Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Antimicrobial Efficacy Testing ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Antimicrobial Efficacy Testing Growth Accelerators and Market Barriers
Table 37. North America Antimicrobial Efficacy Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Antimicrobial Efficacy Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Antimicrobial Efficacy Testing Growth Accelerators and Market Barriers
Table 40. Europe Antimicrobial Efficacy Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Antimicrobial Efficacy Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Antimicrobial Efficacy Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Antimicrobial Efficacy Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Antimicrobial Efficacy Testing Growth Accelerators and Market Barriers
Table 45. Southeast Asia Antimicrobial Efficacy Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Antimicrobial Efficacy Testing Investment Opportunities and Key Challenges
Table 47. Central and South America Antimicrobial Efficacy Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Antimicrobial Efficacy Testing Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Antimicrobial Efficacy Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Charles River Laboratories Corporation Information
Table 51. Charles River Laboratories Description and Major Businesses
Table 52. Charles River Laboratories Product Models, Descriptions and Specifications
Table 53. Charles River Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Charles River Laboratories Sales Value Proportion by Product in 2024
Table 55. Charles River Laboratories Sales Value Proportion by Application in 2024
Table 56. Charles River Laboratories Sales Value Proportion by Geographic Area in 2024
Table 57. Charles River Laboratories Antimicrobial Efficacy Testing SWOT Analysis
Table 58. Charles River Laboratories Recent Developments
Table 59. WuXi AppTec Corporation Information
Table 60. WuXi AppTec Description and Major Businesses
Table 61. WuXi AppTec Product Models, Descriptions and Specifications
Table 62. WuXi AppTec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. WuXi AppTec Sales Value Proportion by Product in 2024
Table 64. WuXi AppTec Sales Value Proportion by Application in 2024
Table 65. WuXi AppTec Sales Value Proportion by Geographic Area in 2024
Table 66. WuXi AppTec Antimicrobial Efficacy Testing SWOT Analysis
Table 67. WuXi AppTec Recent Developments
Table 68. Eurofins Scientific Corporation Information
Table 69. Eurofins Scientific Description and Major Businesses
Table 70. Eurofins Scientific Product Models, Descriptions and Specifications
Table 71. Eurofins Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Eurofins Scientific Sales Value Proportion by Product in 2024
Table 73. Eurofins Scientific Sales Value Proportion by Application in 2024
Table 74. Eurofins Scientific Sales Value Proportion by Geographic Area in 2024
Table 75. Eurofins Scientific Antimicrobial Efficacy Testing SWOT Analysis
Table 76. Eurofins Scientific Recent Developments
Table 77. SGS Corporation Information
Table 78. SGS Description and Major Businesses
Table 79. SGS Product Models, Descriptions and Specifications
Table 80. SGS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. SGS Sales Value Proportion by Product in 2024
Table 82. SGS Sales Value Proportion by Application in 2024
Table 83. SGS Sales Value Proportion by Geographic Area in 2024
Table 84. SGS Antimicrobial Efficacy Testing SWOT Analysis
Table 85. SGS Recent Developments
Table 86. Intertek Group Corporation Information
Table 87. Intertek Group Description and Major Businesses
Table 88. Intertek Group Product Models, Descriptions and Specifications
Table 89. Intertek Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Intertek Group Sales Value Proportion by Product in 2024
Table 91. Intertek Group Sales Value Proportion by Application in 2024
Table 92. Intertek Group Sales Value Proportion by Geographic Area in 2024
Table 93. Intertek Group Antimicrobial Efficacy Testing SWOT Analysis
Table 94. Intertek Group Recent Developments
Table 95. Nelson Laboratories Corporation Information
Table 96. Nelson Laboratories Description and Major Businesses
Table 97. Nelson Laboratories Product Models, Descriptions and Specifications
Table 98. Nelson Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Nelson Laboratories Recent Developments
Table 100. Microbac Laboratories Corporation Information
Table 101. Microbac Laboratories Description and Major Businesses
Table 102. Microbac Laboratories Product Models, Descriptions and Specifications
Table 103. Microbac Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Microbac Laboratories Recent Developments
Table 105. Almac Group Corporation Information
Table 106. Almac Group Description and Major Businesses
Table 107. Almac Group Product Models, Descriptions and Specifications
Table 108. Almac Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Almac Group Recent Developments
Table 110. North American Science Associates Corporation Information
Table 111. North American Science Associates Description and Major Businesses
Table 112. North American Science Associates Product Models, Descriptions and Specifications
Table 113. North American Science Associates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. North American Science Associates Recent Developments
Table 115. Toxikon Corporation Information
Table 116. Toxikon Description and Major Businesses
Table 117. Toxikon Product Models, Descriptions and Specifications
Table 118. Toxikon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Toxikon Recent Developments
Table 120. Pacific Biolabs Corporation Information
Table 121. Pacific Biolabs Description and Major Businesses
Table 122. Pacific Biolabs Product Models, Descriptions and Specifications
Table 123. Pacific Biolabs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Pacific Biolabs Recent Developments
Table 125. MSL Solution Providers Corporation Information
Table 126. MSL Solution Providers Description and Major Businesses
Table 127. MSL Solution Providers Product Models, Descriptions and Specifications
Table 128. MSL Solution Providers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. MSL Solution Providers Recent Developments
Table 130. Accugen Laboratories Corporation Information
Table 131. Accugen Laboratories Description and Major Businesses
Table 132. Accugen Laboratories Product Models, Descriptions and Specifications
Table 133. Accugen Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Accugen Laboratories Recent Developments
Table 135. Consumer Product Testing Company Corporation Information
Table 136. Consumer Product Testing Company Description and Major Businesses
Table 137. Consumer Product Testing Company Product Models, Descriptions and Specifications
Table 138. Consumer Product Testing Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Consumer Product Testing Company Recent Developments
Table 140. Lucideon Corporation Information
Table 141. Lucideon Description and Major Businesses
Table 142. Lucideon Product Models, Descriptions and Specifications
Table 143. Lucideon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Lucideon Recent Developments
Table 145. BioScience Laboratories Corporation Information
Table 146. BioScience Laboratories Description and Major Businesses
Table 147. BioScience Laboratories Product Models, Descriptions and Specifications
Table 148. BioScience Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. BioScience Laboratories Recent Developments
Table 150. ALS Limited Corporation Information
Table 151. ALS Limited Description and Major Businesses
Table 152. ALS Limited Product Models, Descriptions and Specifications
Table 153. ALS Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. ALS Limited Recent Developments
Table 155. Microchem Laboratory Corporation Information
Table 156. Microchem Laboratory Description and Major Businesses
Table 157. Microchem Laboratory Product Models, Descriptions and Specifications
Table 158. Microchem Laboratory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Microchem Laboratory Recent Developments
Table 160. Oxford Biosciences Ltd. Corporation Information
Table 161. Oxford Biosciences Ltd. Description and Major Businesses
Table 162. Oxford Biosciences Ltd. Product Models, Descriptions and Specifications
Table 163. Oxford Biosciences Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Oxford Biosciences Ltd. Recent Developments
Table 165. Abbott Analytical Corporation Information
Table 166. Abbott Analytical Description and Major Businesses
Table 167. Abbott Analytical Product Models, Descriptions and Specifications
Table 168. Abbott Analytical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Abbott Analytical Recent Developments
Table 170. Helvic Laboratories Corporation Information
Table 171. Helvic Laboratories Description and Major Businesses
Table 172. Helvic Laboratories Product Models, Descriptions and Specifications
Table 173. Helvic Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Helvic Laboratories Recent Developments
Table 175. Honeyman Group Limited Corporation Information
Table 176. Honeyman Group Limited Description and Major Businesses
Table 177. Honeyman Group Limited Product Models, Descriptions and Specifications
Table 178. Honeyman Group Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. Honeyman Group Limited Recent Developments
Table 180. Danish Technological Institute Corporation Information
Table 181. Danish Technological Institute Description and Major Businesses
Table 182. Danish Technological Institute Product Models, Descriptions and Specifications
Table 183. Danish Technological Institute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 184. Danish Technological Institute Recent Developments
Table 185. BluTest Laboratories Limited Corporation Information
Table 186. BluTest Laboratories Limited Description and Major Businesses
Table 187. BluTest Laboratories Limited Product Models, Descriptions and Specifications
Table 188. BluTest Laboratories Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 189. BluTest Laboratories Limited Recent Developments
Table 190. Key Raw Materials Distribution
Table 191. Raw Materials Key Suppliers
Table 192. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 193. Milestones in Production Technology Evolution
Table 194. Distributors List
Table 195. Market Trends and Market Evolution
Table 196. Market Drivers and Opportunities
Table 197. Market Challenges, Risks, and Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Efficacy Testing Product Picture
Figure 2. Global Antimicrobial Efficacy Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Preservative Efficacy Testing Product Picture
Figure 4. Disinfectant Efficacy Testing Product Picture
Figure 5. Global Antimicrobial Efficacy Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceutical Manufacturing
Figure 7. Cosmetics and Personal Care Product
Figure 8. Medical Device
Figure 9. Others
Figure 10. Antimicrobial Efficacy Testing Report Years Considered
Figure 11. Global Antimicrobial Efficacy Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 13. Global Antimicrobial Efficacy Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Antimicrobial Efficacy Testing Revenue Market Share by Region (2020-2031)
Figure 15. Global Antimicrobial Efficacy Testing Sales (2020-2031) & (K Units)
Figure 16. Global Antimicrobial Efficacy Testing Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Antimicrobial Efficacy Testing Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Antimicrobial Efficacy Testing Sales Volume Market Share in 2024
Figure 19. Global Antimicrobial Efficacy Testing Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Preservative Efficacy Testing Revenue Market Share by Manufacturer in 2024
Figure 22. Disinfectant Efficacy Testing Revenue Market Share by Manufacturer in 2024
Figure 23. Global Antimicrobial Efficacy Testing Sales Market Share by Type (2020-2031)
Figure 24. Global Antimicrobial Efficacy Testing Revenue Market Share by Type (2020-2031)
Figure 25. Global Antimicrobial Efficacy Testing Sales Market Share by Application (2020-2031)
Figure 26. Global Antimicrobial Efficacy Testing Revenue Market Share by Application (2020-2031)
Figure 27. North America Antimicrobial Efficacy Testing Sales YoY (2020-2031) & (K Units)
Figure 28. North America Antimicrobial Efficacy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Antimicrobial Efficacy Testing Sales Revenue (US$ Million) in 2024
Figure 30. North America Antimicrobial Efficacy Testing Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Antimicrobial Efficacy Testing Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Antimicrobial Efficacy Testing Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Antimicrobial Efficacy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Antimicrobial Efficacy Testing Sales Revenue (US$ Million) in 2024
Figure 40. Europe Antimicrobial Efficacy Testing Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Antimicrobial Efficacy Testing Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 45. France Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Antimicrobial Efficacy Testing Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Antimicrobial Efficacy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Antimicrobial Efficacy Testing Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Antimicrobial Efficacy Testing Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Antimicrobial Efficacy Testing Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 60. India Antimicrobial Efficacy Testing Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Antimicrobial Efficacy Testing Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Antimicrobial Efficacy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Antimicrobial Efficacy Testing Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Antimicrobial Efficacy Testing Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Antimicrobial Efficacy Testing Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Antimicrobial Efficacy Testing Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Antimicrobial Efficacy Testing Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Antimicrobial Efficacy Testing Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Antimicrobial Efficacy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Antimicrobial Efficacy Testing Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Antimicrobial Efficacy Testing Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Antimicrobial Efficacy Testing Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Antimicrobial Efficacy Testing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Antimicrobial Efficacy Testing Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Antimicrobial Efficacy Testing Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Antimicrobial Efficacy Testing Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Antimicrobial Efficacy Testing Revenue (2020-2025) & (US$ Million)
Figure 81. Antimicrobial Efficacy Testing Industry Chain Mapping
Figure 82. Regional Antimicrobial Efficacy Testing Manufacturing Base Distribution (%)
Figure 83. Global Antimicrobial Efficacy Testing Production Market Share by Region (2020-2031)
Figure 84. Antimicrobial Efficacy Testing Production Process
Figure 85. Regional Antimicrobial Efficacy Testing Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Antimicrobial Efficacy Testing market?
The top companies in the global Antimicrobial Efficacy Testing market are Charles River Laboratories、WuXi AppTec、Eurofins Scientific.
What was the global market size of Antimicrobial Efficacy Testing in 2031?
Which region is expected to have the highest market share?
What was the global market size of Antimicrobial Efficacy Testing in 2025?
What is the annual compound growth rate of the global Antimicrobial Efficacy Testing market size from 2025 to 2031?
Related Reports
Antimicrobial Efficacy Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antimicrobial Efficacy Testing was estimated to be worth US$ 338 million in 2025 and is projected to reach US$ 439 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 159
USD 3950.00
(Single User License)
Global Antimicrobial Efficacy Testing Market Research Report 2026
The global Antimicrobial Efficacy Testing market was valued at US$ 338 million in 2025 and is anticipated to reach US$ 439 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 147
USD 2900.00
(Single User License)
Global Antimicrobial Efficacy Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antimicrobial Efficacy Testing market size was US$ 326 million in 2024 and is forecast to a readjusted size of US$ 425 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 114
USD 4250.00
(Single User License)
Antimicrobial Efficacy Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antimicrobial Efficacy Testing was estimated to be worth US$ 326 million in 2024 and is forecast to a readjusted size of US$ 425 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 166
USD 3950.00
(Single User License)
Global Antimicrobial Efficacy Testing Market Research Report 2025
The global market for Antimicrobial Efficacy Testing was valued at US$ 326 million in the year 2024 and is projected to reach a revised size of US$ 425 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published Date: 2025-01-13
Pages: 110
USD 2900.00
(Single User License)
Global Antimicrobial Efficacy Testing Market Research Report 2024
Efficacy Testing is a set of procedures in product research and development that are conducted to test the product’s intended purpose in order to substantiate those all-important claims that appear on your packaging or in your advertisements.
Published Date: 2024-01-14
Pages: 109
USD 2900.00
(Single User License)
Antimicrobial Efficacy Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antimicrobial Efficacy Testing was estimated to be worth US$ 338 million in 2025 and is projected to reach US$ 439 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 159
USD 3950.00 (Single User License)Global Antimicrobial Efficacy Testing Market Research Report 2026
The global Antimicrobial Efficacy Testing market was valued at US$ 338 million in 2025 and is anticipated to reach US$ 439 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 147
USD 2900.00 (Single User License)Global Antimicrobial Efficacy Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antimicrobial Efficacy Testing market size was US$ 326 million in 2024 and is forecast to a readjusted size of US$ 425 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 114
USD 4250.00 (Single User License)Antimicrobial Efficacy Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antimicrobial Efficacy Testing was estimated to be worth US$ 326 million in 2024 and is forecast to a readjusted size of US$ 425 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 166
USD 3950.00 (Single User License)Global Antimicrobial Efficacy Testing Market Research Report 2025
The global market for Antimicrobial Efficacy Testing was valued at US$ 326 million in the year 2024 and is projected to reach a revised size of US$ 425 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-01-13
Pages: 110
USD 2900.00 (Single User License)Global Antimicrobial Efficacy Testing Market Research Report 2024
Efficacy Testing is a set of procedures in product research and development that are conducted to test the product’s intended purpose in order to substantiate those all-important claims that appear on your packaging or in your advertisements.
Published: 2024-01-14
Pages: 109
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now